Clinical Trial Results TV
Antiplatelets: 44 submissions (showing 16 to 30)

| Page 1 | Page 2 | Page 3 |

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Popma and Dr. Gibson discuss safety and efficacy with DES at TCT 08
Dr. Jeff Popma, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Dangas and Dr. Gibson discuss Interruption of Dual Antiplatelet Therapy
, Dr. C. Michael Gibson, Dr. George Dangas

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Gerald Naccarelli and Dr. James Reiffel Discuss What is New With Anticoagulants and Atrial Fibrillation
Dr. Gerald Naccarelli, Dr. James Reiffel

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Leonardo Tamariz presents: Inappropriate Clopidogrel Adherence Explains Stent Related Adverse Outcomes
Dr. Leonardo Tamariz

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Victor Serebruany and Dr. C. Michael Gibson discuss the PLUTO-Diabetes trial
Dr. Victor Serebruany, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Patrick Gladding Presents the Results of the PRINC Trial
, Dr. Patrick Gladding

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Germano Di Sciascio discusses the ARMYDA-Reload study
Dr. Germano DiSciascio

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Laurent Bonello presents the results of the VASP trial
Dr. Laurent Bonello

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Steve Wiviott and Dr. Paul Gurbel Discuss Antiplatelet Resistance
Dr. Paul Gurbel, Dr. Stephen Wiviott

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. David J. Moliterno Discusses the TRA-PCI Trial
Dr. David Moliterno

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Magnus Ohman discusses evidence-based medicine therapies for ACS
Dr. Magnus Ohman

1 Star 2 Star 3 Star 4 Star 5 Star
Safety and efficacy of preoperative thienopyridines in the ACUITY Trial
Dr. Ramin Ebrahimi

1 Star 2 Star 3 Star 4 Star 5 Star
TRIP: Thrombotic Risk Progression by Paul A. Gurbel, MD
Dr. Paul Gurbel

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Eric Peterson provides an update on the CRUSADE and ACTION Registries
Dr. Eric Peterson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Germano DiSciascio discusses the results of the ARMYDA-5 trial at ACC 2007
Dr. Germano DiSciascio